SCHEMBL30612149

SCHEMBL30612149

CC(C)n1ccc2nc(Cl)cc(C=O)c21

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.34
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MPI P34949 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TYR P14679 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26106823 1.00 ALDH1A1 (0.34) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL26106885 0.80 ALDH1A1 (0.36) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL30612231 0.80 ALDH1A1 (0.36) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL30612212 0.77 ALDH1A1 (0.32) ALDH1A1KDM4ESMN1; SMN2MEN1MAPT
SCHEMBL26108115 0.77 ALDH1A1 (0.32) ALDH1A1KDM4ESMN1; SMN2MEN1MAPT
SCHEMBL31347032 0.77 CYP3A4 (0.35) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL26106959 0.77 CYP3A4 (0.35) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL30611873 0.73 KDM4E (0.32) ALDH1A1KDM4E
SCHEMBL26103813 0.73 KDM4E (0.32) ALDH1A1KDM4E
SCHEMBL30612123 0.72 ALDH1A1 (0.36) ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585252-A Bicyclic heteroaryl containing compounds as IKZF2 degrading agents 翁科皮亚治疗公司和SK生命科学实验室 2025-03-07 — — CN disclosed
EP-4499629-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2025-02-05 — — EP disclosed
WO-2023183919-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) 2023-09-28 — — WO disclosed
Send feedback